DrugPatentWatch Database Preview
Profile for Portugal Patent: 2386294
US Patent Family Members and Approved Drugs for Portugal Patent: 2386294
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Jun 13, 2026 | Gilead Sciences | ATRIPLA | efavirenz; emtricitabine; tenofovir disoproxil fumarate |
➤ Try a Free Trial | Apr 28, 2029 | Gilead Sciences | ATRIPLA | efavirenz; emtricitabine; tenofovir disoproxil fumarate |
➤ Try a Free Trial | Jun 13, 2026 | Gilead Sciences | ATRIPLA | efavirenz; emtricitabine; tenofovir disoproxil fumarate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |